An economically and environmentally acceptable synthesis of chiral drug intermediate L-pipecolic acid from biomass-derived lysine via artificially engineered microbes

Journal of Industrial Microbiology & Biotechnology
Jie ChengQinhong Wang

Abstract

Deficiency in petroleum resources and increasing environmental concerns have pushed a bio-based economy to be built, employing a highly reproducible, metal contaminant free, sustainable and green biomanufacturing method. Here, a chiral drug intermediate L-pipecolic acid has been synthesized from biomass-derived lysine. This artificial bioconversion system involves the coexpression of four functional genes, which encode L-lysine α-oxidase from Scomber japonicus, glucose dehydrogenase from Bacillus subtilis, Δ1-piperideine-2-carboxylase reductase from Pseudomonas putida, and lysine permease from Escherichia coli. Besides, a lysine degradation enzyme has been knocked out to strengthen the process in this microbe. The overexpression of LysP improved the L-pipecolic acid titer about 1.6-folds compared to the control. This engineered microbial factory showed the highest L-pipecolic acid production of 46.7 g/L reported to date and a higher productivity of 2.41 g/L h and a yield of 0.89 g/g. This biotechnological L-pipecolic acid production is a simple, economic, and green technology to replace the presently used chemical synthesis.

References

Feb 6, 1979·Biochemistry·E W Hafner, D Wellner
Jan 23, 1975·Biochimica Et Biophysica Acta·J Hutzler, J Dancis
May 1, 1992·Journal of Bacteriology·C SteffesB P Rosen
Jan 1, 1991·Annual Review of Nutrition·H P Broquist
Jun 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·K A Datsenko, B L Wanner
Apr 13, 2002·Analytical Biochemistry·Jedidah W DansonArthur J L Cooper
May 15, 2002·Bioscience, Biotechnology, and Biochemistry·Tadashi FujiiHiroshi Tsunekawa
Oct 29, 2002·Bioscience, Biotechnology, and Biochemistry·Tadashi FujiiHiroshi Tsunekawa
Jan 19, 2006·Journal of Industrial Microbiology & Biotechnology·Min He
Mar 16, 2006·Journal of the American Chemical Society·Gregory J GattoChristopher T Walsh
Jun 2, 2006·Molecular Systems Biology·Ernesto AndrianantoandroRon Weiss
Sep 9, 2006·Bioscience, Biotechnology, and Biochemistry·Hisashi MuramatsuNobuyoshi Esaki
Sep 18, 2007·Applied Microbiology and Biotechnology·Xueli ZhangL O Ingram
Feb 12, 2008·Current Protocols in Molecular Biology·Lynn ThomasonAmos Oppenheim
Jan 1, 2007·Recent Patents on Biotechnology·Savas Anastassiadis
Dec 29, 2011·Journal of Biotechnology·Alfred Fernández-CastanéJosep López-Santín
Jan 15, 2013·Neurochemical Research·André HallenArthur J L Cooper
Sep 24, 2013·Journal of Molecular Biology·Martina RauschmeierKirsten Jung
Mar 13, 2015·Applied Microbiology and Biotechnology·Lothar Eggeling, Michael Bott
Sep 14, 2015·Journal of Industrial Microbiology & Biotechnology·Young Hoon OhSi Jae Park
Nov 4, 2015·Current Problems in Surgery·Shahid G Farid, Gareth Morris-Stiff
Jun 28, 2016·Applied Microbiology and Biotechnology·Fernando Pérez-GarcíaVolker F Wendisch
Nov 11, 2016·Advances in Biochemical Engineering/biotechnology·Masato Ikeda
Feb 9, 2017·Biotechnology Journal·Fernando Pérez-GarcíaVolker F Wendisch
Aug 2, 2017·Biotechnology Advances·Jan-Philipp SchwarzhansKarl Friehs
Feb 11, 2018·Biotechnology and Bioengineering·Igor VassilevJens O Krömer
Apr 15, 2018·Journal of Industrial Microbiology & Biotechnology·Jie ChengQinhong Wang

❮ Previous
Next ❯

Datasets Mentioned

BETA
MG423617
MG425967

Methods Mentioned

BETA
PCR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.